Viruses as anticancer drugs

This publication has 104 references indexed in Scilit:

• Virus evolution
  Current Opinion in Virology, 2011
• M-T5, the Ankyrin Repeat, Host Range Protein of Myxoma Virus, Activates Akt and Can Be Functionally Replaced by Cellular PIKE-A
  Journal of Virology, 2007
• Infected Cell Carriers: A New Strategy for Systemic Delivery of Oncolytic Measles Viruses in Cancer Virotherapy
  Molecular Therapy, 2007
• Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver
  Human Gene Therapy, 2006
• The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
  British Journal of Cancer, 2006
• Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
  Proceedings of the National Academy of Sciences, 2006
• VSV-tumor selective replication and protein translation
  Oncogene, 2005
• Adaptability costs in immune escape variants of vesicular stomatitis virus
  Virus Research, 2005
• Criteria for the Appropriate Drug Utilisation of Immunoglobulin
  PharmacoEconomics, 1996
• Replicating vectors for gene therapy of cancer: risks, limitations and prospects
  European Journal Of Cancer, 1994